In a significant legal development, a New Jersey appeals court has invalidated a $223.8 million verdict against Johnson & Johnson (J&J) that had been given to four plaintiffs alleging cancer due to asbestos exposure in the company's talc powder products.

US court overturns $223.8 million verdict against J&J in talc cancer case

In a significant ruling, a US court has prohibited Johnson & Johnson from using the bankruptcy of one of its subsidiaries as a means to coerce thousands of cancer patients into dropping their cases and accepting a settlement offer.

US court rejects J&J's bankruptcy strategy for lawsuit settlements

Embattled US pharma giant Johnson & Johnson has brought cheers to the otherwise sombre US stock markets. The pharma giant's new consumer health business, Kenvue, has had an impressive debut on listing day on the US stock exchange.

J&J's new unit Kenvue's blockbuster stock debut

US pharma giant Johnson & Johnson has proposed an $8.9 bn settlement to resolve several lawsuits. The lawsuits allege that Johnson and Johnson's talcum powder products cause cancer. For several years now, J&J has been facing lawsuits of its talcum powder containing traces of asbestos.

Johnson & Johnson offers $8.9 bn talcum powder settlement | World Business News

More than a month after Johnson & Johnson announced that it will stop the sale of its talc-based baby powder globally in 2023, the Indian state of Maharashtra on Friday cancelled the manufacturing licence of the pharmaceutical company.

India: Maharashtra cancels Johnson & Johnson baby powder manufacturing licence

The Maharashtra Food and Drug Administration (FDA) has revoked Johnson & Johnson's baby powder production license for its Mulund factory and ordered the corporation to remove the product from the market.

India: Maharashtra cancels j&j baby powder manufacturing licence over quality concerns

Johnson & Johnson will stop selling their controversial talcum powder which has been linked to multiple cases of cancer in women. The company rejected the cancer links, claiming the decision was influenced by 'evolving consumer trends'. Palki Sharma tells you more.

Gravitas: Johnson & Johnson to stop selling baby powder linked to cancer

In yet another setback for the Johnson & Johnson COVID vaccine jab, the FDA limits its use. According to FTA, 15% cases of TTS have been fatal.

Another setback for Johnson & Johnson COVID vaccine jab as FDA limits its use

In yet another setback to the American pharmaceutical giants, FDA has said that it's limiting the use of the Johnson & Johnson coronavirus vaccine for adults citing the risk of a rare blood clotting syndrome.

United States: FDA limits use of Johnson & Johnson Covid-19 vaccine

In a new analysis, the Food and Drug Administration questioned the strength of evidence that Johnson & Johnson provided in its application for booster shots. A key test used by the company was likely not sensitive enough, the agency suggested, adding that it did not have enough time to independently review much of the raw data from the trials.

FDA analysis suggests J&J has not presented robust evidence for boosters

Johnson & Johnson is recalling five of its sunscreen products after some samples were found to contain low levels of benzene, a chemical that can cause cancer with repeated exposure.

Johnson & Johnson recalls several aerosol sunscreen products after detecting cancer-causing agent

Johnson & Johnson said late Thursday that its single-shot COVID-19 vaccine showed strong promise against the Delta variant and other emerging strains and also provided durable protection against the infection more broadly.

J&J's COVID-19 vaccine shows promise against Delta variant

Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India and is looking at ways to accelerate its availability in the country, the Economic Times reported on Tuesday, citing a company spokesperson.

J&J scraps India Covid vaccine trial, aims to accelerate availability: Report

Pharma giant Johnson and Johnson, accused of fuelling the deadly US opioid crisis has reached a USD 230 million settlement with the state of New York. The company has confirmed that it will stop making or selling opioids in the US.

J&J to stop selling opioids in US, reaches USD 230 mn settlement

The US Food and Drug Administration (FDA) has reported that nearly 60 million doses of the Johnson & Johnson coronavirus vaccine have been disposed off due to possible contamination.

Germany demands replacement of 60 million contaminated J&J vaccine doses

The US Food and Drug Administration said Friday it had told Johnson & Johnson that millions of doses of Covid vaccine produced at a troubled plant can't be used because of possible contamination issues.

US tells J&J millions of vaccine doses from troubled plant can't be used

The US Food & Drug Administration on Friday, June 11, said Johnson & Johnson must throw away millions of doses of its COVID-19 vaccine that were manufactured at a problem-plagued Baltimore factory but also cleared millions for use.

US FDA says J&J should discard millions of defected doses

US’ Food and Drug Administration (FDA) has increased the shelf life of the Johnson & Johnson coronavirus vaccine from three to four-and-a-half months. This has come as a piece of good news as millions of doses stored in clinical refrigerators around the world faced the danger of expiring and experts feared they might have to toss out the existing doses.

US: FDA extends shelf-life of J&J vaccine from 3 to 4.5 months

Foreign secretary Harsh V Shringla has said that India is in talks with global vaccine manufacturers such as Pfizer, Johnson & Johnson, and Moderna for local manufacturing of coronavirus vaccines.

India in talks with Pfizer, J&J, Moderna for local manufacturing of covid vaccines: FS Harsh Shringla

Scientists in Germany are claiming to have solved the mystery behind blood clots from AstraZeneca and J&J vaccines. The study says spliced spike proteins may be responsible for the rare side effect. Palki Sharma gets you a report.

Gravitas: Scientists claim to have solved the blood clot puzzle

German researchers on Wednesday said that based on laboratory research they have found the cause of rare but serious blood clotting events among some people who have received COVID-19 vaccine made by AstraZeneca and Johnson & Johnson.

German researchers claimed to have found cause of blood clotting events

The US Centers for Disease Control and Prevention said on Wednesday it had found more cases of potentially life-threatening blood clotting among people who received the Johnson & Johnson COVID-19 vaccine and sees a "plausible causal association".

US CDC finds more clotting cases after J&J vaccine, sees causal link

A Canadian government advisory panel on Monday recommended the use of the Johnson & Johnson vaccine for people aged 30 years and over, despite blood clotting fears. Shelley Deeks of the National Advisory Committee on Immunization (NACI) said the J&J jab has proven to be 'highly effective' in preventing severe COVID-19 infections and hospitalizations.

Canada recommends J&J jab for 30 years and over, despite blood clot fears

For Poles, the May long weekend is usually a time for grilling, socializing and drinking. But in the middle of a pandemic, there is no normal life. So thousands across Poland stood in pouring rain, waiting in line to get a Johnson & Johnson COVID-19 jab instead.

Thousand across Poland stood in the pouring rain for J&J COVID-19 jab

J&j, News on J&j, stories on J&j, articles on J&j, J&j stories at Wion, J&j news, J&j latest news

jj